iiinova — where your digital self keeps evolving

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 24/09/2026

"The evidence is clear: These immunizations continue to provide meaningful protection against severe illness and hospitalization, especially for those at greatest risk. We also found no new safety concerns in comparative studies.” - @mtosterholm.bsky.social Learn more: bit.ly/4x0nIhW

03520

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 24/09/2026

In holding true to the fear that I had, measles continues to challenge us in this country. We are going to, I think, see an ever increasing number of cases occur over the upcoming months. Listen to the latest episode of the Osterholm Update podcast for the full discussion on measles and more. ⬇️

0189

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 23/09/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & @mtosterholm.bsky.social will discuss: -Measles -Ebola -An update on CIDRAP’s Vaccine Integrity Project & more! 🎧 Episode 218 posts Thursday, 9/24. More on the podcast: bit.ly/3ThfmV5

0149

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 16/09/2026

Parents and clinicians need to trust that vaccine recommendations are grounded in a comprehensive and transparent review of the best available science. Our job is to look carefully at the evidence – wherever it leads – and make that evidence accessible. Read the full press release ⬇️

0186

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 11/09/2026

This respiratory virus season, we have the evidence. We have vaccine recommendations from medical societies. We need to listen, encourage vaccination supported by evidence & have answers about the diseases we're trying to prevent & the vaccines that help prevent them bit.ly/4ywBees @medpagetoday.com

bit.ly

Opinion | The Vaccine Recommendations Are Out. Now Comes the Hard Part.

Clinician conversations with patients will matter more than ever

0168

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 10/09/2026

I'm convinced the politics of measles will challenge us in so many more ways than we ever thought of. Keeping facts as facts is so critical, and yet I see it slipping away into the debates about measles. Listen to episode 217 for the full discussion on measles and more ⬇️

12110

Reposted by Michael Osterholm, PhD, MPH

University of Minnesota Consortium on Law and Values @umnconsortium.bsky.social · 03/09/2026

Congrats @mtosterholm.bsky.social & @cidrap.bsky.social's Vaccine Integrity Project: 4 new papers reviewing COVID-19, flu & RSV vaccines. Findings show protection from severe illness, hospitalization & death. CIDRAP is a Consortium member center. Read the papers: www.cidrap.umn.edu/vaccine-inte...

Screenshot of a JAMA Perspective titled “Respiratory Season Virus Vaccines: Restoring Confidence and Trust,” by Sandra Adamson Fryhofer, Andrea M. Garcia, Michael T. Osterholm, et al. Osterholm’s affiliation is the Vaccine Integrity Project, Center for Infectious Disease Research and Policy, University of Minnesota.

02113

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 03/09/2026

"Our objective: Provide clinicians & medical societies w/ a transparent, rigorous assessment of the latest evidence so immunization recommendations remain grounded in the best available science.” -VIP Executive Director @mtosterholm.bsky.social Learn more: bit.ly/4x0nIhW

Quote by Dr. Michael Osterholm, Vaccine Integrity Project Executive Director

Text reads, "Immunization continues to be one of our best tools for preventing severe illness from respiratory viruses."

CIDRAP and Vaccine Integrity Project logos are included.

33513

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 03/09/2026

VIP completed an evidence review of respiratory virus immunizations against influenza, COVID-19 & RSV. ✅ These immunizations continue to provide meaningful protection against severe illness, hospitalization & death ✅ No new safety concerns identified Learn more: bit.ly/4x0nIhW @jama.com

02712

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 03/09/2026

Here’s what the evidence found on the flu, COVID-19 and RSV immunizations. ⬇️ There were no new safety concerns in comparative studies when examining currently recommended immunizations. Review the full reports, published in @jama.com: bit.ly/4x0nIhW

Graphic titled "VIP released an independent evidence review of respiratory virus immunizations." Includes logos of the Vaccine Integrity Project and CIDRAP. Text states, "Here's what the evidence found on the flu, COVID-19 and RSV immunizations." A rightward arrow is shown against a blue background with virus illustrations. CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image.

Text reads, "The influenza review found:
Among adults over 65, the flu vaccine increased protection against hospitalization by 31%.*
Vaccine effectiveness was 80% against laboratory-confirmed influenza-associated deaths among infants and children aged 6 months to 17 years.**
*according to an analysis of VISION Network data
** in a case-cohort analysis of national surveillance data over eight seasons (2016-2020, 2021-2025)"
CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image.

Text reads, "The COVID-19 review found:
For adults over 65, vaccination cut the risk of COVID-related hospitalization by 53% in the 2025-26 respiratory virus season.

Maternal vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58% and to infants aged 0-2 months too with a vaccine effectiveness range of 50-54%.

Vaccinated young children (9 months-4 years) saw a 76% reduction in COVID-related pediatric emergency department visits."

CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image.

Text reads, "The RSV review found:
For adults over 60, studies showed significant protection against hospitalization, with vaccine effectiveness ranging from 69%-83% within the same season as vaccination.

Vaccination during pregnancy reduced the risk of RSV among vaccinees by 82% and also reduced the risk of RSV-associated hospitalization among infants born subsequently.

The infant monoclonal antibody immunization nirsevimab reduced the risk of RSV-related hospitalization by 64%-93% within 6-12 months."

CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

16739

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 02/09/2026

Graphic with the title "What to know: The Vaccine Integrity Project’s independent evidence review of respiratory virus immunizations: Influenza, COVID-19, and respiratory syncytial virus (RSV)." Features the logos of the Vaccine Integrity Project and CIDRAP, with a blue arrow pointing to the right. The background is a teal gradient with a dotted pattern.

The image is a graphic from The Vaccine Integrity Project. Text reads, "The Vaccine Integrity Project reviewed hundreds of peer-reviewed studies published since August 2025, building on its 2025-26 evidence review of vaccine effectiveness, safety and disease epidemiology data.

The evidence found that these immunizations continue to provide meaningful protection against severe illness, hospitalization and death."

The background is teal with dots, and the website vaxintegrity.cidrap.umn.edu is included at the bottom.

The image contains text on a teal background promoting the Vaccine Integrity Project and CIDRAP.
Graphic with arrow pointing to text that reads, "Led by the Vaccine Integrity Project, the review also examined new safety data published since summer 2025 and identified no new safety concerns in comparative studies when examining currently recommended immunizations."

The Vaccine Integrity Project's website address vaxintegrity.cidrap.umn.edu is in the bottom right corner.

The image contains text on a teal background promoting the Vaccine Integrity Project and CIDRAP. It features an arrow pointing to text, "Based on the most recent peer-reviewed data, the review gives Americans the information they need to make vaccination decisions that will help protect themselves and their families from the three leading causes of serious respiratory virus-related illness."

Logos for the Vaccine Integrity Project and CIDRAP are at the bottom, next to the website address vaxintegrity.cidrap.umn.edu.

12914

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 02/09/2026

At a moment when conversation about vaccines has become political, what has happened this year offers a different model. Scientists, physicians, public health experts and medical organizations recognized a gap and worked together to fill it. More on the work of VIP ⬇️

0279

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 02/09/2026

This year’s review confirms that the newest evidence remains consistent with research showing these immunizations reduce the risk of hospitalization and death among the people most likely to experience serious disease. More on VIP's evidence review: bit.ly/4x0nIhW

02110

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 27/08/2026

This back to school season things seem chaotic & confusing, and there can be the temptation to tune out everything. I strongly encourage you to stay the course, remain informed. When it comes to your children's health, talk to your pediatrician, family practitioner &/or nurse practitioner. Listen ⬇️

1209

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 14/08/2026

I spoke w/ @cnn.com on the FDA approved mRNA flu vaccine for use in older adults. Given that mRNA vaccines can be manufactured quickly, this affords us more flexibility in trying to match up the right strain of virus circulating w/ what's in the vaccine. cnn.it/4wqQb0k

cnn.it

The FDA approved the first mRNA flu vaccine for use in older adults. Here’s what to know | CNN

For older adults, the flu vaccine could look a little different this year.

2257

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 13/08/2026

I want to emphasize that all the information that was shared Monday at the White House should be totally disregarded. It is dangerous. And hopefully parents will understand that was not a responsible sharing of information. For the full discussion, listen to episode 215⬇️

0398

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 12/08/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of the next episode. Chris & @mtosterholm.bsky.social will answer questions from listeners on: -Attacks on Dr. Anthony Fauci -White House Executive Order & more! 🎧 Episode 215 posts 8/13 bit.ly/3ThfmV5

0187

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 11/08/2026

CIDRAP Op-Ed: What the vaccine executive order gets wrong, and what it will cost us President Trump said nothing bad can happen. Bad things have already happened, and more are coming. Full Op-Ed by @jakescottmd.bsky.social: bit.ly/4ht8QEY 📷: Wellcome / Wikimedia Commons

23823

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 11/08/2026

What has been promoted in this administration as gold standard science is really a dose of fool's gold. What they stated had no factual basis whatsoever. It was ideology. That is very dangerous. Children will die because we will see fewer kids getting vaccinated.

15014

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 10/08/2026

In response to today’s White House Executive Order (EO) on vaccines, parents should continue to rely on evidence-based immunization recommendations developed by experts. Today's EO does not change the scientific evidence supporting childhood immunization. That data has been built over decades.

22739269

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 03/08/2026

Viruses do not care about politics. The next pandemic will arrive whether we are ready or not. History will judge us by whether we learned enough from it to protect the next generation. Read my full commentary below ⬇️

05024

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 31/07/2026

A pandemic is not just something that happens in one localized area. In the modern world, a pandemic is almost always a viral infection. Read the full conversation that I had with @cidrap.bsky.social News about pandemics. ⬇️

0217

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 30/07/2026

It is interesting how many things we've learned about foodborne disease and specifically Cyclospora. Yet at the same time, it feels like we haven't learned that much. I hope we will recognize there were many, many mistakes made in this outbreak & that we learn from these mistakes. bit.ly/4fsGlG2

bit.ly

Cyclospora: Then and Now

Cyclospora cases continue to climb in the U.S. but this isn’t the first time we’ve had a multi-state outbreak linked to produce. Back in 1996, there was a major cyclospora outbreak across several stat...

0199

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 28/07/2026

This is a complicated outbreak. There’s no question about that. The lack of federal public comment has been very challenging, because people have looked to the federal government to give them clarity of what’s happening. That absence has allowed this big black hole for information. Full story ⬇️

12615

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 23/07/2026

Today, I spoke at the 2026 Big Ten Retirees Association Conference. My talk focused on the important work at @cidrap.bsky.social by the Vaccine Integrity Project (VIP) and how higher education creatively allowed for VIP to play a larger role in the overall vaccine policy landscape.

A photo of Dr. Michael Osterholm at a podium speaking. One hand is raised in the air at shoulder height.

A conference room filled with people listening to Dr. Michael Osterholm speaking at a podium.

1214

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 16/07/2026

Many are concerned with the cyclospora outbreak in the US. The bottom line for this outbreak is, in time, it will be solved. We will understand why the distribution of product was as it was. I hope we also learn that we don't have a monolithic US food supply for leafy greens. Listen: bit.ly/44zpDOV

bit.ly

Cyclospora, Ticks, and Mosquitoes: Summertime Threats

We all look forward to summer, that time of year when we can spend more time outside and less time worrying about things like colds and flu. However, the warm summer months can bring their own infecti...

0154

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 15/07/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & @mtosterholm.bsky.social will discuss: -Cyclosporiasis outbreak -Alpha-Gal syndrome -West Nile virus & more! 🎧 Episode 213 posts Thurs., 7/16. More on the podcast: bit.ly/3ThfmV5

1198

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 14/07/2026

Here's what we know and what we don't know about the huge US Cyclospora outbreak. ⬇️ As the outbreak continues, identifying the source of Cyclospora remains a challenge. Read more: bit.ly/4w3Ezkv

42520

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 14/07/2026

We could be much better prepared for the future. On this episode of @stanforddeptmed.bsky.social's The Future of Medicine podcast, I share lessons learned from COVID-19, pandemic preparedness, and more. Thanks again to @euanashley.bsky.social & @stanfordmedicine.bsky.social. Full conversation ⬇️

1156

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 08/07/2026

Is laughter contagious? 🦠 Later this month, I'll join the Theater of Public Policy to discuss the latest in infectious disease. This unique event uses humor to take the pressure off of serious conversations. 📅 Come ready to learn and laugh on 7/28: bit.ly/4wsotRa

Theater of Public Policy event poster features the phrase "Is Laughter Contagious? (and other public health ponderables)" with an image of Dr. Michael Osterholm as a featured speaker. Event details include Tuesday, July 28th at 7 pm, located at Bryant Lake Bowl. Website link: dangerboat.net/upcoming. Blue virus icons are used as design elements.

2147

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 02/07/2026

In episode 212, we talk about Ebola in the DRC. This Ebola outbreak may be the biggest public health challenge that I have seen in my career. We know what to do, we know how to do it, but the conditions on the ground make a major roadblock to doing what we need to do. ow.ly/IL3550ZjMk8

ow.ly

Episode 212: Major Roadblocks

As the Ebola crisis continues to escalate in the DRC, we must ask: what will it take to end this outbreak? This is one of many questions Chris Dall and Dr. Michael Osterholm will discuss in this week’...

1166

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 01/07/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & @mtosterholm.bsky.social will discuss: -Ebola -A flu outbreak -Initiatives by VIP & The Evidence Collective 🎧 Episode 212 posts Thursday, 7/2. More info on the podcast: ow.ly/1WPU50YVgIo

0147

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 26/06/2026

In an interview with Vaccine Insights, I talked about how the next pandemic will not wait: universal vaccines, pandemic preparedness, and the integrity of vaccine policy. For more on these topics, and to hear about the Vaccine Integrity Project at @cidrap.bsky.social, visit: ow.ly/f08u50ZhFqL

ow.ly

The next pandemic will not wait: universal vaccines, pandemic preparedness, and the integrity of vaccine policy

“What the field needs is better translation of complex immunogenicity and benefit‑risk data into terms that are meaningful to clinicians, public health practitioners, and the public.”Ashling Cannon, C...

0134

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 24/06/2026

More than 60 years after ACIP was established, this is an opportunity to assess how an independent scientific advisory process can best serve the country in an increasingly complex scientific, technological, and political environment. Read more on the initiatives: ow.ly/FLsx50Zgf24

ow.ly

CIDRAP's Vaccine Integrity Project and The Evidence Collective Launch Complementary Initiatives to Strengthen Vaccine Policy and Governance in the United States | Vaccine Integrity Project

CIDRAP provides advice, information and analysis on the prevention, control and treatment of targeted infectious diseases and in public health preparedness.

0143

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 18/06/2026

In this country, 92-94% of all funding for local & state public health activities around infectious diseases actually results from federal support. So, when that federal support is pulled, it really is a challenge in terms of supporting infectious disease surveillance & follow-up. ow.ly/QLJl50ZekKh

cidrap.umn.edu

Episode 211: A System Held With Duct Tape

This week, Chris Dall and Dr. Michael Osterholm bring the latest on the Ebola outbreak in the DRC, what the World Cup means from a public health perspective, as well as explain what screwworm is and h...

12613

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 17/06/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & Dr. Osterholm will discuss: -Ebola outbreak -Hantavirus -New World screwworm & more! 🎧 Episode 211 posts this Thursday, 6/18. More info on the podcast: ow.ly/1WPU50YVgIo

0173

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 12/06/2026

When it comes to treating measles illness, basically, you’re always a day behind, treating the signs and symptoms of what happened yesterday. Read more on declining vaccination rates and measles treatment alternatives: ow.ly/aJGy50ZbgJa @nytimes.com

nytimes.com

With Measles Roaring Back, the Search for a Treatment Is On

0209

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 04/06/2026

This week's podcast episode focuses on Ebola: What the Past Tells Us about the Present. I hope that we, as well as our international partners, can step up to help. We know that we can effectively support an Ebola response. The question, sadly, is whether we will. Listen here: ow.ly/J8FC50Z7J0m

ow.ly

Episode 210: Ebola: What the Past Tells Us about the Present

This week on the Osterholm Update, Dr. Michael Osterholm and Chris Dall focus on the developing Ebola outbreak in the Democratic Republic of Congo, discussing the U.S. response, whether transmission c...

0146

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 03/06/2026

CIDRAP Op-Ed: What’s the likely next move after the executive order on childhood vaccines? It's either a bluff or, more likely, a strategic undermining of the schedule for these life-saving immunizations. Op-Ed by @unbiasedscipod.bsky.social's Jess Steier: ow.ly/miL550Z7bO9

Close-up of a chessboard with chess pieces in soft focus under warm sunlight.

0166

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 02/06/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & @mtosterholm.bsky.social will discuss: -Ebola -Hantavirus -The targeted strain for this fall’s COVID vaccines & more! 🎧 Episode 210 posts Thurs., 6/4. More on the podcast: ow.ly/1WPU50YVgIo

0116

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 27/05/2026

The VIP, w/ @ama-assn.org & medical societies, shared progress on work to support an independent, transparent review of evidence across influenza, COVID-19, & RSV vaccines. This upcoming review will provide carefully evaluated evidence & recommendations grounded in science, medicine & patient care.

1215

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 22/05/2026

I spoke with Becker's Hospital Review on the current Ebola outbreak in the DRC. I shared why I think case counts will go up- but at the same time- I still caution against panic. Read the full interview: ow.ly/bCtB50Z3mXt.

ow.ly

Ebola case count rises to 750: 5 updates

Ebola case count rises to 750 in Congo and Uganda; WHO raises risk level and U.S. enforces travel restrictions amid outbreak.

0192

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 21/05/2026

My @postopinions.bsky.social commentary: Pathogens exploit delays, complacency & political fatigue. They move through cracks we allow to form in public health systems & international partnerships. Outbreaks can be contained if the US and its partners rapidly coordinate efforts. ow.ly/ogne50Z2VTq

ow.ly

Opinion | This Ebola outbreak is a test the world doesn’t have to fail

The U.S. and international partners can act decisively to end this outbreak.

02715

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 21/05/2026

On this episode, I explain why we all should be concerned about what's happening right now with Ebola. But, the concern should be for the people living in the DRC & surrounding countries, not for the possibility this will cause widespread disease & death in the US. Full episode: ow.ly/GYlO50Z2Qq1

ow.ly

Episode 209: Awareness vs. Alarm: Making Sense of the Headlines

In Episode 209, Dr. Michael Osterholm and Chris Dall talk through the response to the hantavirus outbreak and the lingering questions about how the virus spreads. They also discuss a recent Ebola outb...

14314

Reposted by Michael Osterholm, PhD, MPH

CIDRAP @cidrap.bsky.social · 20/05/2026

Chris Dall, co-host of the Osterholm Update podcast, shares a sneak peek 👀 of this week's episode. Chris & @mtosterholm.bsky.social will discuss: -Hantavirus -Ebola -VIP's review of evidence on Tdap vaccination during pregnancy & more! 🎧 Episode 209 posts this Thursday, 5/21. ow.ly/1WPU50YVgIo

02010

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 18/05/2026

The Vaccine Integrity Project at @cidrap.bsky.social published a review of evidence on Tdap vaccination during pregnancy w/ the Evidence Foundation. Our review reinforced that maternal vaccination provides protection for infants before the age they can be vaccinated. Report: ow.ly/uJwF50YZ3ok

02511

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 15/05/2026

There have been over 100 cases of hantavirus in Argentina this past year & no reports of person-to-person transmission. It’s a rare phenomenon, but it happens. Looking at studies, these experiences give reason to believe what is happening on the ship will be self-limited. Full Q&A ow.ly/PxBl50Z0bTw

02110

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 12/05/2026

I spoke with CNN on what we know about the history of hantavirus outbreaks and transmission- and monitoring current hantavirus patients. Interview below ⬇️

12412

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 07/05/2026

I shared my commentary with @postopinions.bsky.social on NIH Director Jay Bhattacharya's failure to release the COVID-19 vaccine effectiveness study in the Morbidity and Mortality Weekly Report. Read the full piece posted to the @washingtonpost.com: ow.ly/LJF850YWkX4

0286

Michael Osterholm, PhD, MPH @mtosterholm.bsky.social · 07/05/2026

One topic on this week's podcast episode, Bad News, Good News, is the 2 clinical trials of Paxlovid. The bad news: Paxlovid is found to have little impact on severe outcomes among most vaccinated patients. The good news: Severe COVID-19 outcomes have become less common. Listen: ow.ly/5uNN50YWcYE

ow.ly

Episode 208: Bad News, Good News

This week on the Osterholm Update, Chris Dall and Dr. Osterholm dissect the latest results of Paxlovid trials and what they tell us about COVID-19. They'll also discuss a CDC study on COVID-19 vaccine...

0223